-
EP3749359
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3749359
| EP3749359 - TREATMENT OF OPHTHALMOLOGIC DISEASES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 03.02.2023 Database last updated on 22.01.2025 | |
| Former | Request for examination was made Status updated on 13.11.2020 | ||
| Former | The international publication has been made Status updated on 17.08.2019 | ||
| Former | unknown Status updated on 20.02.2019 | Most recent event Tooltip | 20.02.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080 / US | [2020/51] | Inventor(s) | 01 /
OSBORNE, Aaron c/o Genentech, Inc. 1 DNA Way South San Francisco, California 94080-4990 / US | 02 /
SAHNI, Jayashree c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | 03 /
WEIKERT, Robert James c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2020/51] | Representative(s) | Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2020/51] | Jenni, Wolfgang Roche Diagnostics GmbH Patent Department (TR-E) Nonnenwald 2 82377 Penzberg / DE | Application number, filing date | 19703978.7 | 05.02.2019 | [2020/51] | WO2019EP52704 | Priority number, date | US201862627103P | 06.02.2018 Original published format: US 201862627103 P | US201862729333P | 10.09.2018 Original published format: US 201862729333 P | [2020/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019154776 | Date: | 15.08.2019 | Language: | EN | [2019/33] | Type: | A1 Application with search report | No.: | EP3749359 | Date: | 16.12.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.08.2019 takes the place of the publication of the European patent application. | [2020/51] | Search report(s) | International search report - published on: | EP | 15.08.2019 | Classification | IPC: | A61K39/395, A61P27/02, C07K16/22 | [2020/51] | CPC: |
A61K39/3955 (EP,IL);
A61K39/00 (IL);
C07K16/22 (EP,IL,KR,US);
A61P27/02 (EP,IL,KR,US);
A61K2039/505 (IL,KR,US);
A61K2039/545 (IL,KR,US);
C07K2317/31 (EP,IL,KR,US);
C07K2317/35 (EP,IL,KR);
C07K2317/565 (IL,US);
C07K2317/71 (EP,IL,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/51] | Title | German: | BEHANDLUNG VON OPHTHALMOLOGISCHEN ERKRANKUNGEN | [2020/51] | English: | TREATMENT OF OPHTHALMOLOGIC DISEASES | [2020/51] | French: | TRAITEMENT DE MALADIES OPHTHALMOLOGIQUES | [2020/51] | Entry into regional phase | 07.09.2020 | National basic fee paid | 07.09.2020 | Designation fee(s) paid | 07.09.2020 | Examination fee paid | Examination procedure | 07.09.2020 | Examination requested [2020/51] | 07.09.2020 | Date on which the examining division has become responsible | 28.06.2021 | Amendment by applicant (claims and/or description) | 07.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 07.09.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 15.11.2023 | Reply to a communication from the examining division | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 15.11.2023 | Request for further processing filed | 15.11.2023 | Full payment received (date of receipt of payment) Request granted | 23.11.2023 | Decision despatched | 28.06.2021 | Request for further processing filed | 28.06.2021 | Full payment received (date of receipt of payment) Request granted | 06.07.2021 | Decision despatched | Fees paid | Renewal fee | 09.02.2021 | Renewal fee patent year 03 | 09.02.2022 | Renewal fee patent year 04 | 09.02.2023 | Renewal fee patent year 05 | 20.02.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2014009465 (ROCHE GLYCART AG [CH]); | [X]WO2014177459 (HOFFMANN LA ROCHE [CH], et al); | [XI]US2016215045 (LEUNG DONMIENNE DOEN MUN [US], et al); | by applicant | US5202238 | US5204244 | WO9627011 | WO9845331 | WO9850431 | WO2007110205 | EP1870459 | WO2007147901 | WO2009080253 | WO2009089004 | WO2010040508 | WO2010129304 | WO2011090754 | WO2011090762 | WO2011117329 | WO2011143545 | WO2012058768 | WO2012131078 | WO2013096291 | WO2013157954 | WO2013157953 | WO2014009465 | WO2015083978 | WO2017197199 |